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ABSTRACT 
 
 
Aims: To determine whether, based on the current literature, bariatric surgery prior to total hip 
(THR) or total knee replacement (TKR) reduces complication rates and improves outcome 
following arthroplasty. 
 
Materials and Methods: Systematic literature search was undertaken of published and 
unpublished databases on the 5th November 2015. All papers reporting studies comparing people 
who had undergone bariatric surgery versus not prior to THR or TKR were included. Each study 
was assessed using the Downs and Black appraisal tool. A meta-analysis of risk ratios (RR) and 
95% confidence intervals was performed to determine the incidence of complications including 
wound infection, deep vein thrombosis (DVT), pulmonary embolism (PE), joint revision and 
mortality. 
 
Results: From 156 potentially studies, five papers were eligible. In total 23,348 (657 bariatric 
surgery, 22,691 non-bariatric surgery) participants were analysed. The evidence-base was moderate 
in quality. There was no statistically significant difference in outcomes such as superficial wound 
infection (RR: 1.88), deep wound infection (RR: 1.04), DVT (RR: 0.57), PE (RR: 0.51), joint 
revision (RR: 1.24) or mortality (RR: 1.25) between the two groups. 
 
Conclusions: For the majority of peri-operative outcomes, bariatric surgery prior to THR or TKR 
does not significantly reduce complication rates or improve clinical outcomes.   
 
Clinical Relevance: This study questions the previous notion that bariatric surgery prior to joint 
replacement may improve clinical outcomes for people who are obese or morbidly obese. 
 
Keywords: Joint replacement; obesity; gastric bypass; gastric band; wound; function 
 
PROSPERO Registration Number: CRD42015028037 
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INTRODUCTION 
 
Osteoarthritis is a leading cause of musculoskeletal disability and reduced quality of life in adults.1 
Joint replacement (or arthroplasty) is the surgical option for end-stage osteoarthritis when symptom 
management with conservative strategies is insufficient.2 
 
Obesity is considered a major problem facing UK public health services. 3 Obesity is defined using 
body mass index (BMI). People with a BMI of 20 kg/m2 to 30 kg/m2 are considered ‘normal’ body 
mass, 30 kg/m2 to 40 kg/m2 are categorised as obese, and greater than 40 kg/m2 are considered 
morbidly obese.4 Approximately 62% of the UK population have a BMI of 30 or over.3 
 
People with osteoarthritis have been acknowledged to be of greater risk of weight gain and higher 
BMI due to reduced physical activity.5 Surgical intervention for people who are obese may be 
associated with increased risk of complications such as deep and superficial wound infection, 
myocardial infarction (MI) and stroke.6-8 Furthermore previous papers have acknowledged that 
people who are obese have a poorer clinical outcome after hip or knee replacement.9,10  
 
To address these differences in outcomes and perceived post-operative complications, some 
arthroplasty candidates have undergone bariatric surgery procedures prior to their total hip (THR) 
or total knee replacement (TKR).11 Such procedures have included gastric bypass, sleeve 
gastrectomy, stomach partition using staples and gastric balloon insertion. The alternative to 
surgical interventions has been for such individuals to receive dietary advice, psychological support 
on behaviour change interventions and physical activity interventions to promote compliance to 
long-term weight loss strategies.12,13  Previous reviews have investigated the clinical outcomes of 
each of these interventions for people with hip or knee osteoarthritis.14,15 These have reported a 
significant greater improvement in pain, function and stiffness in people following bariatric surgery 
compared to those not offered bariatric surgery. However no systematic reviews have been 
undertaken assessing whether there is a difference in outcomes (peri-operative and longer-term) 
between those who receive bariatric surgery compared to those who do not prior to THR or TKR. 
The purpose of this study was to answer this question based on the current evidence-base.  
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MATERIALS AND METHODS 
 
Search Strategy 
 
A primary search was performed of the electronic published literature databases EMBASE, AMED, 
CINAHL, MEDLINE, and the Cochrane Registry of Clinical Trials. A search was also performed 
of unpublished literature databases including OpenGrey, clinicaltrials.gov, the WHO clinical trial 
registry, the ISRCTN and the NIHR trial portfolio. The search strategy was modified for each 
individual database (Supplementary Table 1). All databases were reviewed from their inception 
to the 5th November 2015. The reference lists were reviewed of all potentially eligible studies and 
review papers identified on the preliminary search. Finally, the corresponding authors of all 
included studies were contacted and asked to review the results and declare whether any additional 
papers should be included. 
 
Eligibility Criteria 
 
All studies assessing outcomes of people who were determined obese or morbidly obese and who 
underwent any form of bariatric surgery before THR or TKR compared to people who were obese 
or morbidly obese and did not receive bariatric surgery before THR or TKR were included. All 
study designs comparing these two groups were included. We therefore included randomised and 
non-randomised controlled trials. Bariatric surgical interventions included gastric band, gastric 
bypass, sleeve gastrectomy, stomach partitioning using staples and gastric balloon insertion with 
or without a behaviour and dietary intervention. We included all papers irrespective of age, source 
or language of publication. 
 
Study Identification 
 
The titles and abstracts of all search results were independently reviewed by two reviewers (TS, 
TA) against the eligibility criteria. The full-texts of all citations which were deemed potentially 
eligible were obtained. These were then re-reviewed against the eligibility criteria.  If there was 
disagreement between the two reviewers, this was resolved through discussion or adjudicated by a 
third reviewer (AM). 
 
Outcome Measures 
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The primary outcome was the frequency of post-operative complications within the initial 12 month 
post-operative period. Potential post-operative complications included superficial and deep wound 
infection, deep vein thrombosis (DVT), pulmonary embolism (PE), joint revision or mortality. 
Secondary outcomes included inpatient readmission, clinical outcomes such as the Oxford Hip 
Score16 or Oxford Knee Score17, length of hospital stay, pain score and patient-reported quality of 
life measured with tools such as the EQ-5D-5L.18 Secondary outcomes were measured to 24 months 
post-operatively. Outcomes were analysed as either inpatient, shorter-term (hospital discharge to 
90 days), intermediate-term (three months to six months), and longer-term (six months onwards). 
  
Data Extraction 
 
Data were collected by one reviewer (TA) and verified by a second (TS). Where disagreement in 
data collection occurred, this was resolved through discussion. Data extracted included: cohort 
mean age, gender mix, surgical procedure, American Society of Anaesthesiologists (ASA) score, 
BMI at arthroplasty procedure, and the outcomes of interest.  
 
Quality Assessment 
 
All included studies were assessed with quality assessment tools. As all the studies were non-
randomised controlled trials, the Down and Blacks19 tool was adopted. Each paper was reviewed 
by one reviewer (TA) and verified by a second (TS). Cases of disagreement between the two 
reviewers were resolved through discussion and adjudicated by a third reviewer (AM). 
 
Data Analysis 
 
The data extraction tables were reviewed for study heterogeneity. In cases where there was study 
heterogeneity in respect to participant characteristics, bariatric surgery interventions within the 
cohorts, outcome measures and study design, a narrative review of the findings was undertaken. 
Where these study characteristics were homogeneous, a meta-analysis was undertaken. Statistical 
heterogeneity was assessed using the inconsistency-value (I2) and Chi-squared tests. In cases where 
I2 was ≤20% and Chi-squared equated to p≤0.10, a fixed-effects model meta-analysis was 
undertaken. When these were not satisfied, a random-effects meta-analysis was undertaken. For all 
continuous outcomes e.g. Oxford Knee Score, patient-reported quality of life, length of stay and 
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pain, the mean difference was calculated with 95% confidence intervals (CI). For all dichotomous 
outcomes such as complications or readmission, a relative risk (RR) was estimated with 95% 
confidence intervals. For all analyses, p<0.05 denoted statistically significance.  
 
Subgroup analyses which were planned a priori included comparison of the intervention to control 
group on clinical outcomes stratified by age (less than 65 years versus 66 years and over), BMI 
group (less than or equal to BMI 40 versus BMI greater than 40), by arthroplasty type (THR versus 
TKR) and by duration of arthroplasty from bariatric surgery (e.g. TKR within or longer than two 
years). All analyses were undertaken by two reviewers (TS, TA) using Revman Version 5.3 
(Review Manager, RevMan). Copenhagen: The Nordic Cochrane Centre, The Cochrane 
Collaboration, 2014). 
 
The analysis for each outcome was evaluated using the GRADE approach by two reviewers (TA, 
TS).20 This approach evaluates the quality of evidence for each analysis undertaken (i.e. the body 
of the literature forming that particular analysis as opposed to the whole evidence irrespective of 
whether it was used in an analysis or not). Using this, the quality of evidence was categorised into 
four possible levels: high, moderate, low or very low quality.20 
 
 
RESULTS 
 
Search Strategy 
 
A total of 156 citations were identified from the search strategy. From these, five were deemed 
eligible (Figure 1). These were all non-randomised controlled trials.  
 
Characteristics of Included Studies 
 
A summary of the characteristics of the included studies is presented in Table 1. In total 23,348 
participants were included in this analysis. A total of 6632 males and 16,572 females were recruited 
with a mean age of 63.2 years (range: 53 years21 to 64 years22). Kulkarni et al21 did not present data 
on the number of males and females in their cohort. The analysis cohort considered of 657 
participants who received bariatric surgery and 22,691 who did not receive bariatric surgery. No 
studies documented the type of bariatric surgery procedure which was undertaken in their cohorts. 
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Total knee replacement was performed in 20,636 people whilst 2709 underwent THR; three 
underwent hip resurfacing in Kulkarni et al’s21 cohort. The mean BMI at arthroplasty was 36.1 
kg/m2 in the bariatric cohort and 42.9 kg/m2 in the non-bariatric cohort. Two studies did not present 
the BMI data for their cohort.21,23 Two studies presented the data as classified by whether 
participants had received bariatric surgery within or longer than two years before their arthroplasty 
procedure.22,24 The other three studies did not document the duration between bariatric surgery and 
arthroplasty for their cohorts.  
 
Quality Assessment 
 
The quality of the research was largely moderate to good (Table 2). Recurrent strengths presented 
across the five studies included clearly stating the study aims and objectives, participant 
characteristics, surgical procedures and potential confounders to influence the outcome. All five 
papers clearly presented the findings of their results and presented both point and variance data for 
clinical scores and adverse events.  
 
The evidence-base however presented with a number of important limitations. Firstly, one study 
did not present its data using probability values and did not adjust for different lengths of follow-
up.22 Due to their retrospective nature, none of the studies randomised participants to group 
allocation, and it was not logistical to blind participants to whether or not they received bariatric 
surgery. Three studies recruited both cases and controls at the same time.21-23 Finally no studies 
performed a power calculation to determine whether they analysed sufficient numbers of 
participants to detect a statistically significant difference.  
 
Meta-Analyses 
 
A summary of the results of the meta-analyses are presented in Table 3. 
 
Primary Outcome 
 
All five studies presented data on post-operative complications at 30 days post-operatively.21-25  On 
meta-analysis, there was no significant difference between those who underwent bariatric surgery 
to those that did not for superficial wound infection (RR: 1.88, 95%CI: 0.95 to 3.73), deep wound 
infection (RR: 1.04; 95% CI: 0.65 to 1.66), DVT (RR: 0.57, 95% CI: 0.13 to 2.44) and PE (RR: 
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0.51, 95% CI: 0.03 to 8.26). There was no statistically significant difference in re-operation rates 
for joint revision from 12 months22  to 14 years24 post-arthroplasty (RR: 1.24, 95% CI: 0.75 to 2.05; 
p=0.40) or mortality (RR: 1.25, 95% CI: 0.16 to 9.89).  
 
There was however a significant difference in favour of those who received pre-arthroplasty 
bariatric surgery for the assessment of post-operative infection requiring or not-requiring irrigation 
and draining.21,23 There was a statistically significant greater risk of wound infection (with or 
without irrigation and drainage) for the non-bariatric surgery group (RR: 0.36, 95% CI: 0.15 to 
0.90; p=0.03; N=11656; I2: 0%; p=0.86; Figure 2).  
 
One study assessed the difference in post-operative THR prosthesis dislocation between those who 
underwent bariatric surgery pre-arthroplasty compared to non-bariatric surgery.21 They reported no 
statistically significant difference between the intervention arms (RR: 1.18, 95% CI: 0.11 to 12.68; 
N=143) 
 
Two studies reported the frequency of complications at 90-days follow-up.22,24 There was no 
significant difference for this outcome between those who underwent compared to those who did 
not undergo bariatric surgery pre-arthroplasty (RR: 0.63, 95% CI: 0.32 to 1.26; N=11328; I2: 0%; 
p=0.96). 
 
Two studies presented data on inpatient readmission.21,22 On meta-analysis, there was no 
statistically significant difference between the bariatric versus non-bariatric surgery groups (RR: 
0.57, 95% CI: 0.06 to 5.09, p=0.62, N=11346, I2: 74%, p=0.05). 
 
These analyses on post-operative complications were assessed as ‘very low’ quality of evidence 
using the GRADE approach. Accordingly, there is very little confidence in the effect estimate due 
to inconsistency in results, imprecision and risk of bias.20 
 
Secondary Outcomes 
 
Length of hospital stay was measured in two studies.21,22  There was insufficient data to analyse 
this outcome through meta-analysis. On narrative review there was no statistically significant 
difference between those who received bariatric compared to non-bariatric surgery pre-arthroplasty 
(p>0.05).  
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Two studies presented data on the frequency of post-operative blood transfusion with people 
following TKR.23,24 On meta-analysis, there was no statistically significant difference in 
requirement for post-operative blood transfusion between the two bariatric management cohorts 
(RR: 2.30, 95% CI: 0.23 to 23.05, p=0.48, N=11638, I2: 46%; p=0.17). On GRADE assessment, 
these findings were considered of ‘low’ quality due to risk of bias and imprecision. There is 
therefore limited confidence in the effect estimate, and the true estimate may be substantially 
different from the estimate of the effect.20 
 
No studies assessed pain scores, patient-reported quality of life, nor clinical outcomes with 
functional and patient-reported scoring systems such as the Harris Hip Score or the Oxford Hip or 
Knee Scores. 
 
Subgroup Analyses 
  
There was insufficient data to perform subgroup analyses by age and BMI category. However, there 
was sufficient data to perform subgroup analyses by duration of arthroplasty from bariatric surgery 
(i.e. TKR within or longer than two years). Based on this, there was no significant difference in the 
occurrence of deep wound infection (RR: 0.73, 95% CI: 0.09 to 5.81, p=0.76, N=257, I2: 0%, 
p=0.94), joint revision (RR: 0.91, 95% CI: 0.11 to 7.83, p=0.93, N=257, I2: 47%, p=0.17) or 90-
day post-operative complications (RR: 0.43, 95% CI: 0.10 to 1.82, p=0.25, N=257, I2: 16%, p=0.27) 
for those who underwent TKR within or longer than two years post-bariatric surgery. As per the 
initial analysis, on GRADE assessment, these subgroup findings were considered of ‘low’ quality 
due to risk of bias and imprecision. There is therefore limited confidence in the effect estimate and 
the true estimate may be substantially different from the estimate of the effect.20 
 
 
DISCUSSION 
 
The findings of this systematic review indicate that for the majority of outcomes there is no 
significant difference in the frequency of peri-operative complications and post-operative clinical 
outcomes between those who do compared to those who do not undergo bariatric surgical 
procedures prior to THR or TKR. Only overall medical complications (collectively assessed) and 
wound infection (requiring or not requiring irrigation and drainage) showed a significant risk ratio, 
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favouring the bariatric surgery group. Whilst the evidence-base was moderate in quality, the 
GRADE analysis determined that the analyses were ‘low’ or ‘very low’ quality, and therefore 
should be viewed with some caution. Nonetheless these findings are contrary to previous belief that 
bariatric surgery may be a valuable surgical option to reduce the risks of poor clinical outcome for 
people prior to arthroplasty procedure.  
 
Whilst the non-bariatric surgery groups included in these analyses presented with higher BMI 
measurements pre-arthroplasty compared to the bariatric surgery groups, this difference ranged 
from 0kg/m2 25 to 7.6 kg/m2.22 Therefore the difference between groups on the principle causative 
factor (i.e. BMI) was of little difference in studies such as Martin et al.25.  Accordingly the 
difference in clinical outcomes between those people with high versus lower BMI may still be 
evident and undisputed by this analysis. There is also some confusion, due to poorly reporting 
previous non-bariatric interventions which these cohorts may have received, regarding alternative 
intervention which may have been used as weight reduction management strategies. Therefore the 
findings of this analysis may provide an insight as to whether or not bariatric surgery confers any 
additional benefit over and above non-surgical approaches to weight reduction. To determine this, 
future studies should ensure that previous non-surgical interventions which patients may have 
received, should be reported to determine how surgery relates to other weight management 
strategies.  
 
There was insufficient data to compare the threshold for arthroplasty after bariatric surgery. 
Kulkarni et al21 described a minimum of six months following bariatric surgery as sufficient, 
assuming the level of obesity between their bariatric surgery and non-bariatric surgery groups was 
similar. Severson et al24 and Inacio et al22 divided their groups into non-bariatric surgery, total joint 
arthroplasty (TJA) or TKR within two years of bariatric surgery, and TJA or TKR more than two 
years after bariatric surgery. The aim of performing bariatric surgery pre-arthroplasty has been to 
decrease a patient’s BMI pre-surgery, however no mention has been made on whether a target BMI 
was stipulated pre-arthroplasty. Whilst three of the papers reported their group’s BMI at the time 
of arthroplasty,22,24,25 this data was not provided for Werner et al23 or Kulkarni et al21 studies. Whilst 
there appears limited indication  that BMI post-bariatric surgery (or whether it is bariatric surgery 
itself) plays a role in arthroplasty outcomes, because of this omission from two studies21,23, this 
uncertainty requires answering during future analyses as the evidence-base develops. 
 
12 
Whilst the evidence-base provided important data on complication and adverse event data, there is 
a paucity of clinical or health economic data on bariatric surgery versus non-bariatric surgery 
interventions prior to arthroplasty. Data from patient reported outcome measures and longer-term 
functional outcomes is also lacking to inform clinical decision-making on staged bariatric surgery. 
These are two very important omissions in the current evidence-base and are therefore research 
priorities to ensure that healthcare commissioners and health service users can be better informed 
on what could be the global health outcomes of these procedures pre-arthroplasty. A well-designed, 
pragmatic randomised controlled trial investigating the clinical and cost-effectiveness of bariatric 
surgery on THR and TKR outcomes with a sufficient follow-up period, is therefore warranted to 
better understand the recommendations (or not) of bariatric surgery prior to arthroplasty procedures 
for people with high BMI.  
 
This study presented with three important limitations. Firstly, data from three papers22,23,25 were 
based on hospital and healthcare system datasets and registries, which were gathered through 
hospital coding systematic. Therefore errors in cataloguing and coding of procedures may have 
been a source of errors in subsequent data analyses. Secondly, whilst meta-analyses are partly 
aimed to overcome the issue statistical error through pooling homogenous datasets, due to such 
lower numbers of events of medical complications such as DVT, PE, MI and stroke, the findings 
of this analysis may therefore be affected by Type II error. Further analyses as datasets develop 
may therefore be indicated to assess for this potential limitation. Finally, this paper provides 
valuable data on outcomes principally within the first 18 months post-arthroplasty. This therefore 
provides insights into the potential differences in complications and recovery phases, but is 
insufficient when evaluating longer-term outcomes. Future trials should therefore analyse outcomes 
between those who undergo bariatric surgery and those who do not pre-arthroplasty to analyse the 
affect of this management approach on mid- to longer-term implant survival and revision 
procedures.   
 
To conclude, bariatric surgery prior to THR or TKR may not significantly reduce the risk of 
complications post-arthroplasty. There is insufficient evidence to ascertain whether bariatric 
surgery prior to THR or TKR is cost-effective in relation to patient reported outcomes and quality 
of life as well as health utilisation in the longer-term. There is insufficient evidence to support or 
refute the use of bariatric surgical procedures for this population until the evidence-base in the form 
of prospective pragmatic cost-effectiveness randomised controlled trials is undertaken. Only then 
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will healthcare commissions, professionals and the public be sufficiently informed regarding the 
appropriateness of bariatric surgery prior to THR or TKR. 
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Figure 1: A PRISMA flow-chart presenting the search strategy results 
 
Figure 2: Forest plot of wound infection (requiring or not irrigation and drainage) for those who 
received bariatric surgery pre-operatively compared to non-bariatric surgery management prior to 
TKR or THR. 
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randomised studies 
 
Table 3: Results of the meta-analyses 
 
 
Supplementary Table 1: Search strategy for MEDLINE 
 
17 
Figure 1: A PRISMA flow-chart presenting the search strategy results 
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Figure 2: Forest plot of wound infection (requiring or not irrigation and drainage) for those who 
received bariatric surgery pre-operatively compared to non-bariatric surgery management prior to 
TKR or THR. 
 
 
 
 
 
 
 
 
 
 
Table 1: Characteristics of included studies 
 
Study Name 
 
Inacio [22] Kulkarni [21] Martin [25] Severson [24] Werner [23] 
N  
 
11203 143 364 125 11513 
N (Bariatric Surgery) 
 
<2y: 102 
>2y: 69 
90 91 86 219 
N (Non-Bariatric Surgery) 
 
11032 53 273 39 11294 
Gender (M/F) 
 
3575/7628 ND 68/296 26/99 2963/8550 
Mean age in years 
(SD/range) 
 
BS (<2y):  57.0(6.8) 
BS (>2y): 59.9 (7.8) 
nBS: 63.8 (8.7) 
BS: 57 
nBS: 53 
BS: 58.1 (8.0) 
nBS (high BMI): 57.4 (7.0)  
nBS (low BMI) 58.7 (7.0) 
BS (<2y): 59.3 (7.5) 
BS (>2y) 59.0 (8.4) 
nBS: 55.5 (6.5) 
ND 
Frequency of surgical 
procedure (THR/TKR) 
THR: 2653/ TKR: 8550 BS: 37 THR/ 53 TKR 
nBS: 19 THR/3 
resurfacing; 31 TKR 
TKR TKR TKR 
Mean BMI in kg/m2 
(SD/range) 
 
BS (<2y): 32.4 (4.7)         
BS (>2y): 34.6 (6.2) 
nBS: 40.0 (4.4) 
ND BS: 37.2 (7.0);  
nBS (high BMI) 51.2 (9.0)  
nBS (low BMI) 37.2 (7.0) 
BS (<2y): 37.9 (7.5) 
BS (>2y) 38.5 (9.8) 
nBS: 43.1 (6.3) 
ND 
ASA grade BS (<2y): 1&2: 70; 3≥ 32 
BS (>2y): 1&2: 38; ≥3: 31 
nBS: 1&2: 4315; ≥3: 6598 
Unknown: 119 
ND ND ND ND 
Mean weight in kg (SD) ND ND ND BS (<2y): 104.1 
(19.3)  
BS (>2y) 101.4 
(22.6) 
nBS: 121.5 (19.3) 
ND 
Final Follow-up 12 months 18 months BS: 3.9 years (SD 2) 
nBS (high BMI): 4.1 years 
(SD 2) 
nBS (low BMI): 4.1 years 
(SD 2) 
Range: 22 months to 
14 years 
90 days 
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ASA - American Society of Anesthesiologists; BS – bariatric surgery; F – female; M – male; nBS – not bariatric surgery; ND – not documented; THR – total hip 
replacement; TKR – total knee replacement; SD- standard deviation 
Table 2: Summary of the critical appraisal results using the Downs and Black checklist for non-
randomised studies 
 
 Inacio 
[22] 
Kulkarni 
[21] 
Martin 
[25] 
Severson 
[24] 
Werner 
[23] 
1. Hypothesis/aims/objectives clearly stated Y Y Y Y Y 
2. Main outcome measures clearly described. Y Y Y Y Y 
3. Characteristics of patients/subjects clearly described Y Y Y Y Y 
4. Interventions of interest clearly described Y Y Y Y Y 
5. Distribution of principal confounders in each group clearly 
described 
Y Y Y Y Y 
6. Main findings clearly described Y Y Y Y Y 
7. Estimates of random variability in the data provided Y Y Y Y Y 
8. Important adverse events reported Y Y Y Y Y 
9. Characteristics of patients lost to follow-up described UTD UTD UTD Y UTD 
10. Actual probability values reported  N Y Y Y Y 
11. Participants approached representative of entire population Y Y Y Y Y 
12. Participants recruited representative of entire population Y Y Y Y Y 
13. Staff, places and facilities representative of majority of 
population 
Y Y Y Y Y 
14. Blinding of study subjects N N N N N 
15. Blinding of assessors N N N N N 
16. Data based on data-dredging clearly stated N/A N/A N/A N/A N/A 
17. Adjustment of different length of follow-up or duration between 
case and control 
N Y Y Y Y 
18. Appropriate statistical tests used. Y Y Y Y Y 
19. Compliance to intervention reliable.  Y Y Y Y Y 
20. Main outcome measure reliable and valid Y Y Y Y Y 
21. Intervention groups or case-controls recruited from same 
population 
Y Y Y Y Y 
22. Intervention groups or case-controls recruited at the same time. Y Y N N Y 
23. Study subjects randomized to the interventions N N N N N 
24. Was concealed randomization to allocation undertaken N N N N N 
25. Adequate adjustment made in the analysis of confounders Y UTD Y Y Y 
26. Patient losses accounted for. Y UTD UTD Y UTD 
27. Sufficiently powered cohort size N N N N N 
 
Y – Yes; N – No; UTD – Unable to determine 
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Table 3: Results of the meta-analyses 
 
 
Outcome Risk Ratio 
(95% CI) 
P-value N Statistical 
heterogeneity (I2; 
Chi2 p-value) 
Superficial wound infection 1.88 (0.95, 0.37) 0.07 11,567 0%; 0.46 
Deep wound infection 1.04 (0.65, 1.66) 0.88 22,841 0%; 0.83 
Deep vein thrombosis 0.57 (0.13, 2.44) 0.45 11,710 0%; 1.00 
Pulmonary embolism 0.51 (0.03, 8.26) 0.64 11,346 NE 
Joint revision 1.24 (0.75, 2.05) 0.40 11,835 0%; 0.88 
Mortality 1.25 (0.16, 9.89) 0.84 11,346 0%; 0.76 
In-patient re-admission 0.57 (0.06, 5.09) 0.62 11,346 74%; 0.05* 
Medical complication (collective) 0.54 (0.39, 0.74) <0.01 11,781 0%; 0.74 
Post-operative infection 
(with/without I&D) 
0.36 (0.15, 0.90) 0.03 11,656 0%; 0.86 
Post-operative blood transfusion 2.30 (0.23, 23.05) 0.48 11,638 46%; 0.17* 
Complications within first 90 post-
operative days 
0.63 (0.32, 1.26) 0.19 11,328 0%; 0.96 
 
* denotes that a random-effects analysis model was adopted; CI – confidence intervals; I2 – inconsistency 
value: I&D – irrigation and drainage; N – number of cases 
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Supplementary Table 1: Search strategy for MEDLINE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
1. Exp. Arthroplasty/ 
2. Joint replacement.tw. 
3. Exp. Hip joint/ 
4. Exp. Knee/ 
5. Exp. Obesity/ 
6. Bariatri*.tw. 
7. Obes*.tw. 
8. Weight management.tw. 
9. Weight loss.tw. 
10. Exp. surgery/ 
11. Exp. Operation/ 
12. Operati*.tw. 
13. Gastric band.tw. 
14. Gastric bypass.tw. 
15. Stomach staple.tw. 
16. OR/1,2 
17. OR/3,4 
18. OR/6-9 
19. OR/10-15 
20. AND/16-19 
 
